申请人:AbbVie Inc.
公开号:US20150087618A1
公开(公告)日:2015-03-26
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
本发明描述了可有效抑制丙型肝炎病毒(“HCV”)复制的化合物。本发明还涉及制备此类化合物的过程,包含此类化合物的组合物,以及使用此类化合物治疗HCV感染的方法。